TOLERANCE AND SERUM LEVELS OF HALOPERIDOL DURING PARENTERAL AND ORAL HALOPERIDOL TREATMENT IN GERIATRIC-PATIENTS

被引：21

作者：

VIUKARI, M

SALO, H

LAMMINSIVU, U

GORDIN, A

机构：

[1] ORION PHARMACEUT CO,RES LABS,BOX 19,SF-00101 HELSINKI 10,FINLAND

[2] KOSKELA MUNICIPAL HOSP,SF-00600 HELSINKI 60,FINLAND

来源：

ACTA PSYCHIATRICA SCANDINAVICA | 1982年 / 65卷 / 04期

关键词：

D O I：

10.1111/j.1600-0447.1982.tb00850.x

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：301 / 308

页数：8

共 9 条

[1]

AYD FJ, 1978, J CLIN PSYCHIAT, V39, P807

[2] ANTIPSYCHOTIC-DRUGS STIMULATE PROLACTIN-RELEASE [J].

CLEMENS, JA ;

SMALSTIG, EB ;

SAWYER, BD .

PSYCHOPHARMACOLOGIA, 1974, 40 (02) :123-127

[3] INTRAMUSCULAR HALOPERIDOL DECANOATE FOR NEUROLEPTIC MAINTENANCE THERAPY - EFFICACY, DOSAGE SCHEDULE AND PLASMA-LEVELS - AN OPEN MULTI-CENTER STUDY [J].

DEBERDT, R ;

ELENS, P ;

BERGHMANS, W ;

HEYKANTS, J ;

WOESTENBORGHS, R ;

DRIESENS, F ;

REYNTJENS, A ;

VANWIJNGAARDEN, I .

ACTA PSYCHIATRICA SCANDINAVICA, 1980, 62 (04) :356-363

[4]

FORSMAN A, 1977, CURR THER RES CLIN E, V21, P396

[5]

HEYKANTS J, 1979, COMP PHARMACOKINETIC

[6]

NIEMEGEERS CJE, 1979, R1625DECA1 JANSS PHA

[7]

REYNTJENS AJM, 1982, INT PHARMACOPSYCHIAT

[8]

Siegel S., 1956, NONPARAMETRIC STAT B

[9]

SOLOMON K, 1980, HALOPERIDOL UPDATE 1, P155

← 1 →